Uncategorized

Executives answered questions on the Wednesday earnings call about TAVR’s growth potential and results of a key clinical trial, released earlier this week, comparing the procedure to open-heart surgery.

The company expects to receive FDA approval for its Agent drug-coated balloon and its Farapulse pulsed-field ablation system next year.

The device maker plans to submit the Esprit BTK data to the Food and Drug Administration for review.

Magritek has made benchtop NMR suitable for the rapid identification and quantitation of analytes during chemical reactions, in batch and continuous flow processes.

Numerous studies have outlined how high medical costs affect uninsured individuals, but healthcare prices are straining household budgets regardless of insurance type, according to the Commonwealth Fund.

However, the California insurer’s forecast of $38 billion in premium revenue next year remained unchanged, thanks to new contract wins.

Pramana, Inc. and Techcyte have joined forces to deliver the first intelligent volumetric scanning and digital diagnostics solution for cytology, microbiology, and hematology applications.

Zivo Bioscience, Inc. today announced that the Board of Directors of the Company approved a 1-for-6 reverse stock split (the “Reverse Stock Split”) of its shares of common stock, par value $0.001 (the “Common Stock”) effective at 5:00 p.m. ET on October 26, 2023.

Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced participation in the following scientific and industry conferences in November.

Invertir en criptomonedas se ha vuelto más accesible y eficiente con la ayuda de la Inteligencia Artificial (IA). La gestión de inversiones en criptomonedas impulsada por IA utiliza algoritmos de aprendizaje automático para analizar las tendencias del mercado, lo que conduce a m …